# Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

Study · id `cardio:ct-nct06855537` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06855537](<https://clinicaltrials.gov/study/NCT06855537>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06855537

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2190 participants.

## Technical summary

Registry record NCT06855537. Randomized; no masking; primary purpose prevention. Start 2025-11-03 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 2190 participants (planned count; ClinicalTrials.gov record NCT06855537, source copy `cardio:ctgov-nct06855537-2026-10-16`, retrieved 2026-10-31)
- Started: 2025-11-03 (actual) (ClinicalTrials.gov record NCT06855537, source copy `cardio:ctgov-nct06855537-2026-10-16`, retrieved 2026-10-31)
- Primary completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT06855537, source copy `cardio:ctgov-nct06855537-2026-10-16`, retrieved 2026-10-31)
- Completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT06855537, source copy `cardio:ctgov-nct06855537-2026-10-16`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06855537, source copy `cardio:ctgov-nct06855537-2026-10-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06855537-2026-10-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
- Condition: Coronary Arterial Disease (CAD)
- Condition: Vulnerable Coronary Plaques
- Condition: Thin-cap fIbroatheroma
- Condition: Acute Coronary Syndromes (ACS)
- Intervention (Procedure): PCI strategy
- Intervention (Drug): OMT strategy
- Lead sponsor: Beijing Anzhen Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)

## Provenance

Content hash: 2519044f0c60eb439c3002a4b88655d96ad88e5db1fc67e55307f779a0f02fbd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
